Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | APEX1 | P27695 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | PRKCI | P41743 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.45 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.43 |
| ▸ | MMP12 | P39900 | 1/20 | 0.42 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.42 |
| ▸ | CDK1 | P06493 | 1/20 | 0.42 |
| ▸ | PIM1 | P11309 | 1/20 | 0.42 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.42 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.42 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | NAMPT | P43490 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL22748994 | 0.98 | MAPT (0.68) | MAPTKDM4EALDH1A1APEX1RECQL | |
| SCHEMBL14722647 | 0.83 | MAPT (0.56) | MAPTKDM4EALDH1A1APEX1RECQL | |
| SCHEMBL31156360 | 0.83 | MAPT (1.00) | MAPTKDM4EALDH1A1APEX1RECQL | |
| SCHEMBL30390007 | 0.83 | MAPT (0.61) | MAPTKDM4EALDH1A1APEX1RECQL | |
| SCHEMBL29745115 | 0.83 | MAPT (0.61) | MAPTKDM4EALDH1A1APEX1RECQL | |
| SCHEMBL23124230 | 0.83 | MAPT (0.61) | MAPTKDM4EALDH1A1APEX1RECQL | |
| SCHEMBL3891255 | 0.83 | MAPT (0.61) | MAPTKDM4EALDH1A1APEX1RECQL | |
| SCHEMBL2317063 | 0.83 | MAPT (0.61) | MAPTKDM4EALDH1A1APEX1RECQL | |
| SCHEMBL3891260 | 0.83 | MAPT (0.56) | MAPTKDM4EALDH1A1APEX1RECQL | |
| SCHEMBL30363506 | 0.83 | MAPT (0.85) | MAPTKDM4EALDH1A1APEX1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 709 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025129105-A1 | COMPOSITION AND METHOD FOR DETECTION OF BIOMOLECULES VIA AROMATIC LABELING USING HETEROCYCLIC COMPOUNDS | Life Technologies Corporation (US) | 2025-06-19 | — | — | WO | claimed |
| US-20250199008-A1 | COMPOSITION AND METHOD FOR DETECTION OF BIOMOLECULES VIA AROMATIC LABELING USING HETEROCYCLIC COMPOUNDS | Life Technologies Corporation (US) | 2025-06-19 | — | — | US | claimed |
| CN-120073221-A | Preparation method of diaphragm for improving shock resistance of battery | 扬州纳力新材料科技有限公司 | 2025-05-30 | — | — | CN | claimed |
| EP-3980554-B1 | HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES | HOFFMANN LA ROCHE (CH) | 2025-03-26 | — | — | EP | claimed |
| CN-118164917-A | Alpha-fluoroenamine compound and preparation method and application thereof | 南京工业大学 | 2024-06-11 | — | — | CN | claimed |
| CN-115515643-A | Modified binding polypeptides for optimized drug conjugation | 建新公司 | 2022-12-23 | — | — | CN | claimed |
| CN-107955020-B | Method for synthesizing benzimidazol oxazinone compound by copper salt catalysis in one pot | 西南大学 | 2020-09-22 | — | — | CN | claimed |
| US-20200054664-A1 | METABOLIC SUPPLEMENT FORMULATION AND METHODS OF USE FOR TREATING DEPRESSION AND ANXIETY | HAWKINS GERMAINE BERNARD (US) | 2020-02-20 | — | — | US | claimed |
| EP-1511757-B1 | NEW COMPOUNDS FOR MODULATING THE ACTIVITY OF EXCHANGE PROTEINS DIRECTLY ACTIVATED BY CAMP (EPACS) | UNIV MEDISCH CENTRUM UTRECHT (NL) | 2015-11-04 | — | — | EP | claimed |
| EP-2445518-A1 | COBALAMIN TAXANE BIOCONJUGATES FOR TREATING EYE DISEASE | Osiris Therapeutics, Inc. (US) | 2012-05-02 | — | — | EP | claimed |
| EP-0701448-A4 | AMPLIFICATION OF THE VITAMIN B 12? UPTAKE SYSTEM USING POLYMERS | BIOTECH AUSTRALIA PTY LTD (AU) | 1997-01-02 | — | — | EP | claimed |
| US-5548064-A | COLONY STIMULATING FACTOR; ORAL ADMINISTERING | BIOTECH AUSTRALIA PTY LIMITED (AU) | 1996-08-20 | — | — | US | claimed |
| CN-1126441-A | Amplification of vitamin B12 absorption System Using polymers | BIOTECH AUSTRALIA PTY LTD (AU) | 1996-07-10 | — | — | CN | claimed |
| CN-1126436-A | Vitamin B12 mediated oral delivery systems for GCSF and EPO | BIOTECH AUSTRALIA PTY LTD (AU) | 1996-07-10 | — | — | CN | claimed |
| EP-0701448-A1 | AMPLIFICATION OF THE VITAMIN B 12? UPTAKE SYSTEM USING POLYMERS | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 1996-03-20 | — | — | EP | claimed |
| EP-0700295-A1 | VITAMIN B 12? MEDIATED ORAL DELIVERY SYSTEMS FOR GCSF AND EPO | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 1996-03-13 | — | — | EP | claimed |
| US-5449720-A | Amplification of the VB12 uptake system using polymers | BIOTECH AUSTRALIA PTY LIMITED (AU) | 1995-09-12 | — | — | US | claimed |
| WO-1994027641-A1 | AMPLIFICATION OF THE VITAMIN B12 UPTAKE SYSTEM USING POLYMERS | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 1994-12-08 | — | — | WO | claimed |
| WO-1994027613-A1 | VITAMIN B12 MEDIATED ORAL DELIVERY SYSTEMS FOR GCSF AND EPO | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 1994-12-08 | — | — | WO | claimed |
| CN-1040321-A | 2 ', 5 '-therapeutic use of oligomerization adenylic acid derivant | UNIV TEMPLE (US) | 1990-03-14 | — | — | CN | claimed |